The effect of methimazole (MMI) and 2-mercaptoethanol (ME) on Itransport was studied using phospholipid vesicles (P-vesicles) made from porcine thyroid plasma membranes and soybean phospholipids by sonication.
A theory of Na+-I-cotransport in the thyroid has been proposed on the basis of some experiments using rabbit thyroid slices (Iff and Wilbrandt, 1963) , cultured bovine thyroid cells (Bagchi and Fawcett , 1973) and a unique thyroid cell line (Weiss et al., 1984) . Recently, a biological model Received October 7, 1988 To whom all correspondence and requests for reprints should be addressed. of the thyroidItransport system was developed by the authors (Saito et al., 1982 (Saito et al., , 1983a (Saito et al., , 1983b (Saito et al., , 1984 (Saito et al., , 1985 . The model consists of phospholipid vesicles (Pvesicles2) made from the thyroid plasma membranes (PM) and crude soybean phospholipids by sonication. On the basis of the studies using this model system, a specific I-carrier exists separately from Na+-K+-ATPase in the thyroid PM. The I-carrier, a protein in nature, can transport I-from the external to the internal vesicular space down the concentration gradient of Nat.
We now propose that I-transport mediated by this carrier is Nat-I-cotransport. The role of Na+-K+-ATPase in Itransport in the thyroid cell is only to pump out Nat, generating a concentration gradient of Na+ across PM.
It is generally believed that thionamide drugs, such as methimazole (MMI) and propylthiouracil (PTU), block peroxidasecatalyzed organic binding of I-but do not inhibit I-transport in the thyroid gland. Therefore, they are frequently used in studies of thyroidal I-transport in order to keep intrathyroidal I-unbound (Wolff, 1964; Bastomsky, 1974) . There are some reports indicating that the drugs may alter I-kinetics perhaps without decreasing [-influx. PTU does not decrease I-uptake but rather increases the thyroid/serum ratio of the unbound I-concentration in vivo (Wollmam and Scow, 1953, 1955; Wollman and Reed, 1958) . The reason may be that PTU (Wollman and Reed, 1962; Newcomer, 1967) and MMI (Resenberg et al., 1964) decreases thyroid I-efflux. In this paper we describe the effects of MMI and ME on our model system of I-transport. In this study, PTU was not used because of low solubility, and ME was used as another reducing agent.
Materials and Methods
Porcine thyroid PM were prepared according to the method described previously (Saito et al., 1982) . Phospholipids were prepared from crude soybean phospholipids (L-phosphatidyl choline type IV-S, Sigma) after washing in acetone as described elsewhere (Saito et al., 1982) . In the present study, ME was omitted at each step of phospholipid preparation.
P-vesicles were prepared by a sonication technique (Saito et al., 1982) . The frozen PM (20mg protein) were washed once in the choline+ buffer (175mM choline-Cl, 30mM Tris-HCl and 1.5mM MgSO4, PH 7.4) and resuspended in 2 ml of the same buffer. The PM suspension was put into a tube containing 100mg phospholipids and sonicated with a Branson ultrasonic oscillator using 50% duty cycle pulses (20kHz, 40 watts) for a net 6 min. The resulting clear suspension of P-vesicles was quickly frozen at week) until transport assay. be similar to that in the vesicles iucubated in the presence of MMI as shown in Fig.   1 The effect of NEM treatment was studied and is shown in Fig. 3 
Discussion
The authors have been studying the thyroid I-transport system using P-vesicles made from porcine thyroid PM and soybean phospholipids by sonication (Saito et al., 1982 (Saito et al., , 1983a (Saito et al., , 1983b (Saito et al., , 1984 (Saito et al., , 1985 . The Icarrier can mediate Na+-I-cotransport, as has been postulated on the basis of experiments using thyroid tissue (Iff and Wilbrandt, 1963; Bagchi and Fawcett, 1973; Weiss et al., 1984) . The energy source for I-accumulation in the thyroid cells may be a concentration gradient of Na+ formed by Na+-K+-ATPase.
Although it is evident that MMI is not necessary for preservation of the I-transport activity in the thyroid gland, MMI has frequently been used in studies on Itransport in thyroid tissue (Ahn and Rosenberg, 1970; Bagchi and Fawcett, 1973) . The use of MMI is recommended for the reason that the movement of only unbound I-can be observed, since it blocks Endocrinol.
Japon. June 1989 peroxidase-catalyzed I-organification without inhibiting specific I-transport (Wolff, 1964; Bastomsky 1974) . Of course, Itransport in the thyroid tissue has also been observed without using MMI, when both I-transport and organic binding of Iare intended to be investigated at the same time (Ahn and Rosenberg, 1970; Saito et al., 1981) . But such cases are rather rare.
It has been shown that reducing agents, MMI and ME, do not inhibit Nat-dependent I-transport in our P-vesicles (Saito et al., 1982 (Saito et al., , 1983a (Saito et al., , 1983b (Saito et al., , 1984 (Saito et al., , 1985 . In view of the results of the present study, it is obvious that MMI or ME is necessary for the I-carrier to preserve the action of Natcoupled I-transport. In P-vesicles prepared without MMI or ME, the activity of Natdependent I-transport is recovered, if ME is added later at the beginning of incubation.
It is certain that a reducing agent is necessary at the site of interaction between the I-carrier and I-including Na+ and phospholipids.
In addition, NEM treatment of PM resulted in complete inactivation of Nat-dependent I-transport. This observation is consistent with the idea that the I-carrier in the thyroid PM has at least one active sulfhydryl group, as such a theory has been proposed in a certain sugar transport system (Henderson et al., 1983) . The role of MMI and ME in maintaining the action is to protect this sulfhydryl group. Although there has been a paper suggesting that there exists a sulfhydryl group in the I-transport system in the thyroid gland of mice (Anbar and Inbar, 1964) , this has not yet been confirmed, since there are many active proteins containing sulfhydryl groups other than the Icarrier in the whole thyroid cell. Therefore, the observation indicating the presence of a sulfhydryl group in the carrier in this study is a new finding that cannot be obtained without using our P-vesicle system. It is probable that there exists a mechanism supplying a natural reducing substance to the I-transport system in the physiological thyroid cells. The I--trapping defect may be due to the impairment of such a mechanism, although it is more probable that the disorder is due to structural impairment or loss of the Icarrier.
Although the authors were not aware of the importance of MMI or ME in preserving Nat-dependent I-transport in earlier studies (Saito et al., 1982 (Saito et al., , 1983a (Saito et al., , 1983b (Saito et al., , 1984 (Saito et al., , 1985 , ME was added to the phospholipid preparation.
The final concentration of ME in the incubabation mixture was at least as high as 0.35 mM. That is enough for the I-carrier to maintain the Natdependent I-transport activity. In the present study, Natdependent Itransport was observed at an ME concentration as low as 0.2mM, although non-specific I-uptake (see below) was also observed to a small extent (data not shown).
Rapid I-uptake and a high equilibrium level were observed in the absence of MMI and ME. High I-uptake in this case may not be due to enhanced I-. transport mediated by the I-carrier, since specific characteristics such as Na+ dependency and inhibition by ClO4-are lost. In addition, it has been confirmed that P-vesicles made from only soybean phospholipids without thyroid PM components take up more Iin the absence of any reducing agent than in the presence of ME. The high equilibrium level shown in Fig. 4 indicates that I-taken up by P-vesicles is bound to something composing the vesicles, since Iis not concentrated inside the vesicles at the time of equilibrium because of the loss of specific I-transport. Therefore a portion of the I-may have been oxidized nonenzymatically and subsequently bound to phospholipids (and protein ?) covalently. Such a theory has been proposed by Posner and Ordonez (1970) on the basis of an experiment using thyroid phospholipids.
They have shown that I-binding to phospholipids is enhanced by adding Fe"' and prevented by PTU. Thus, MMI and ME may decrease non-specific I-binding to P-vesicles by inhibiting non-enzymatic oxidation of I-.
The authors once reported a trial of solubilization and reconstitution of the Icarrier (Saito et al., 1986) . We proposed that the activity of I-counterflow which might contain a disulfide bond was reconstituted into P-vesicles. But the idea should be revised, since specific I-transport was recovered by adding ME in the present study. Non-specific I-binding must have been observed in the experiment on solubilization because of the omission of ME. Solubilization and reconstitution of the I-counterflow activity with a disulfide bond has not yet been established, but it has been confirmed that the I-carrier in sonicated P-vesicles can actually mediate I-counterflow in the presence of ME (Saito et al., 1989) . When P-vesicles prepared without thyroid PM are loaded with a high concentration of stable I-prior to incubation, they take up more labeled I-than Pvesicles not loaded with stable I-in the absence of any reducing agent (unpublished observation). The high I-uptake in this instance cannot be explained by covalent I-binding to phospholipids alone, since I--binding sites of phospholipids should have been occupied with stable I-before incubation. Therefore, I-can readily enter Pvesicles through phospholipid bilayer in the absence of MMI or ME, although it is not clear whether I-permeability increases with or without relation to covalent Ibinding to phospholipids.
It is possible that covalent binding of I-to phospholipids is reversible, readily resulting in the exchange of bound I-for unbound I-. In any case, MMI as well as ME decreases the permeability of I-through the bilayer in addition to inhibition of covalent I-binding to lipids without relation to enzymatic I-organiThere have been some reports stating that PTU (Wollman and Reed, 1962; Newcomer, 1967) and MMI (Rosenberg et al., 1964) decrease I-efflux from the thyroid, resulting in an increase in the thyroid/serum ratio of the I-concentration in in vivo experiments Scow, 1953, 1954; Wollman and Reed, 1958) . Iefflux has been considered to be reduced as a result of the inhibition of enzymatic I-organification. Put another explanation for the increased I-concentration ratio in these in vivo experiments can be introduced when the present data are applied. There is usually a considerable amount of Ileakage through the phospholipid bilayer in addition to I-binding to the bilayer of PM, if insufficient reducing agents are present, since the intracellular I-concentration is higher than that outside. The leakage decreases without interfering with the I-carrier, when PTU or MMI is administered, since MMI decreases permeability. We think that an increase in the thyroid/serum ratio of the I-concentration occurs without relation to enzymatic Iorganification, since MMI decreases Ipermeability in our P-vesicles in which peroxidase cannot act because of the absence of H2O2. In any case, the use of MMI in experiments on I-transport using thyroid tissue is recommendable in order to obtain accurate data, by decreasing I-movement not mediated by the carrier in addition to blocking enzymatic I-organification.
ClO4-and SCN-are both seen to be specific competitive inhibitors of thyroid Itransport on the basis of Lineweaver-Burk plot analysis using sheep thyroid slices (Wolff and Maurey, 1963) and our P-vesicle system (Saito et al., 1983b) . But there was a difference in their actions in the present study. ClO4-inhibited only Natdependent I-movement, while SCN-inhibited nonspecific I-uptake by P-vesicles in the absence of ME in addition to inhibition of Nat-dependent I-transport demonstrated in the presence of ME. Although the precise mechanism of the effect of SCN-remains to be elucidated, diminution of nonspecific Iuptake by SCN-may be related to oxidation or reduction of I-, since no such effect was observed in the presence of MMI or ME in the present study. Maloof and Soodak (1966) reported that SCN-can be oxidized and that I-and SCN-oxidation are inhibited by each other. It is probable that the high concentration of SCN-acts as a reducing agent preventing nonenzymatic I-oxidation.
Therefore, C104-is better than SCN-, when these anions are used as blockers of specific I-transport in the thyroid.
SCN-should not be used as a blocker of thyroidal I-transport in the condition in which non-specific I-oxidation is impefectly prevented.
In conclusion, MMI as well as ME has two distinct effects in our model system of thyroid I-transport.
The one is preservation of the Na+-dependent I-transport activity, by protecting an active sulfhydral group in the I -carrier from oxidation. The other is deminution of nonspecific I-binding to phspholipids (and protein ?) other than the carrier, by inhibiting non-specific or non-enzymatic I-oxidation. Although both C104-and SCN-act as specific competitive inhibitors of thyroid I-transport, SCNhas an additional effect in the absence of reducing agents.
SCN-may inhibit nonspecific I-binding to something composing P-vesicles, presumably by acting as a reducing agent inhibiting non-enzymatic Ioxidation.
This idea may be applied to the whole thyroid cells or tissue.
